Indegene Limited Share Price

Equities

INDGN

INE065X01017

Business Support Services

Market Closed - NSE India S.E. 12:43:54 14/06/2024 BST 5-day change 1st Jan Change
585.5 INR -2.44% Intraday chart for Indegene Limited +7.81% 0.00%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 16.65B 199M 15.71B Sales 2023 23.06B 276M 21.77B Capitalization 130B 1.56B 123B
Net income 2022 1.65B 19.73M 1.56B Net income 2023 2.66B 31.86M 2.51B EV / Sales 2022 * -
Net cash position 2022 * - 0 0 Net cash position 2023 * - 0 0 EV / Sales 2023 * -
P/E ratio 2022 *
-
P/E ratio 2023 *
-
Employees 5,181
Yield 2022 *
-
Yield 2023 *
-
Free-Float 30.12%
More Fundamentals * Assessed data
Dynamic Chart
1 day-2.44%
1 week+7.81%
Current month+12.41%
1 month+5.60%
More quotes
1 week
536.10
Extreme 536.1
616.95
1 month
470.10
Extreme 470.1
616.95
Current year
452.00
Extreme 452
660.00
1 year
452.00
Extreme 452
660.00
3 years
452.00
Extreme 452
660.00
5 years
452.00
Extreme 452
660.00
10 years
452.00
Extreme 452
660.00
More quotes
Indegene Limited is a life sciences commercialization company. It provides digital-led commercialization services for the life sciences industry, including biopharmaceutical, emerging biotech, and medical devices companies. The Company operates through four segments: Enterprise Medical Solutions, Enterprise Commercial Solutions, Omnichannel Activation, and Others. Its Enterprise Commercial Solutions segment primarily involve assisting life sciences companies with their digital marketing operations. Its Omnichannel Activation solutions segment help life sciences companies leverage a digital first approach for optimizing the last-mile promotion of biopharmaceutical products and medical devices to healthcare professionals across multiple channels. Under its Enterprise Medical Solutions segment, it establishes centers of excellence to consolidate large scale regulatory and medical operations for its clients. Others segment offers enterprise clinical solutions and consultancy services.
More about the company
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
585.5
Average target price
-
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW